RTTQA
@rttqa.bsky.social
Offial Bluesky account of the National Radiotherapy Trials Quality Assurance (RTTQA) Group in the UK. Views own. Reposts are not endorsements.
We support #WorldRTDay and the multiprofession approach to high quality #clinicaltrials leading to improved treatment and outcomes for our patients #WRAD
September 7, 2025 at 7:24 AM
We support #WorldRTDay and the multiprofession approach to high quality #clinicaltrials leading to improved treatment and outcomes for our patients #WRAD
Reposted by RTTQA
Want the opportunity to work at the forefront of RT #clinicaltrials? We are hiring!
Band 7 Clinical Scientist/Radiographer. 1-year post, renewable subject to funding:
www.enherts-tr.nhs.uk/careers/vaca...
Deadline 18th August.
DM for further information. #medphys #rtt #rtqa
Band 7 Clinical Scientist/Radiographer. 1-year post, renewable subject to funding:
www.enherts-tr.nhs.uk/careers/vaca...
Deadline 18th August.
DM for further information. #medphys #rtt #rtqa
Current vacancies – East and North Hertfordshire NHS Trust
Are you a retired NHS employee? You could join the NHS Retirement Fellowship.
www.enherts-tr.nhs.uk
July 23, 2025 at 10:51 AM
Want the opportunity to work at the forefront of RT #clinicaltrials? We are hiring!
Band 7 Clinical Scientist/Radiographer. 1-year post, renewable subject to funding:
www.enherts-tr.nhs.uk/careers/vaca...
Deadline 18th August.
DM for further information. #medphys #rtt #rtqa
Band 7 Clinical Scientist/Radiographer. 1-year post, renewable subject to funding:
www.enherts-tr.nhs.uk/careers/vaca...
Deadline 18th August.
DM for further information. #medphys #rtt #rtqa
Want the opportunity to work at the forefront of RT #clinicaltrials? We are hiring!
Band 7 Clinical Scientist/Radiographer. 1-year post, renewable subject to funding:
www.enherts-tr.nhs.uk/careers/vaca...
Deadline 18th August.
DM for further information. #medphys #rtt #rtqa
Band 7 Clinical Scientist/Radiographer. 1-year post, renewable subject to funding:
www.enherts-tr.nhs.uk/careers/vaca...
Deadline 18th August.
DM for further information. #medphys #rtt #rtqa
Current vacancies – East and North Hertfordshire NHS Trust
Are you a retired NHS employee? You could join the NHS Retirement Fellowship.
www.enherts-tr.nhs.uk
July 23, 2025 at 10:51 AM
Want the opportunity to work at the forefront of RT #clinicaltrials? We are hiring!
Band 7 Clinical Scientist/Radiographer. 1-year post, renewable subject to funding:
www.enherts-tr.nhs.uk/careers/vaca...
Deadline 18th August.
DM for further information. #medphys #rtt #rtqa
Band 7 Clinical Scientist/Radiographer. 1-year post, renewable subject to funding:
www.enherts-tr.nhs.uk/careers/vaca...
Deadline 18th August.
DM for further information. #medphys #rtt #rtqa
Reposted by RTTQA
We are looking for two exceptional consultant uro-oncologists to come and join our team in Sutton. Please see further details 👇
www.royalmarsden.nhs.uk/current-vaca...
www.royalmarsden.nhs.uk/current-vaca...
Current vacancies | The Royal Marsden
www.royalmarsden.nhs.uk
June 3, 2025 at 6:41 PM
We are looking for two exceptional consultant uro-oncologists to come and join our team in Sutton. Please see further details 👇
www.royalmarsden.nhs.uk/current-vaca...
www.royalmarsden.nhs.uk/current-vaca...
Want to be part of shaping the future direction of RT research in the UK? An exciting opportunity has arisen to work as a research fellow within the @nihr.bsky.social RTTQA Group, based at Mount Vernon Cancer Centre.
For more info please DM us! #radonc #rtqa
www.nhsjobs.com/job/UK/Hertf...
For more info please DM us! #radonc #rtqa
www.nhsjobs.com/job/UK/Hertf...
Job vacancy: Research Fellow National Radiotherapy QA Team, East and North Hertfordshire Teaching NHS Trust, Northwood | trac.jobs
www.nhsjobs.com
June 2, 2025 at 3:18 PM
Want to be part of shaping the future direction of RT research in the UK? An exciting opportunity has arisen to work as a research fellow within the @nihr.bsky.social RTTQA Group, based at Mount Vernon Cancer Centre.
For more info please DM us! #radonc #rtqa
www.nhsjobs.com/job/UK/Hertf...
For more info please DM us! #radonc #rtqa
www.nhsjobs.com/job/UK/Hertf...
Very excited to do the #RTQA for this trial
FAST-Forward Boost is a national breast radiotherapy trial and is investigating whether people with #BreastCancer can be treated with #Radiotherapy with a tumour bed boost as effectively and safely within 1 week instead of 3 weeks.
Read more about the trial here:
Read more about the trial here:
Search - NIHR Funding and Awards
fundingawards.nihr.ac.uk
May 10, 2025 at 8:36 PM
Very excited to do the #RTQA for this trial
Proud to have contributed to this important study #RTQA
At #ESTRO2025, the 10-year results of the FAST-Forward #ClinicalTrial were presented. The results confirmed 5-year findings showing that treating early stage #BreastCancer with #Radiotherapy to the breast & chest wall over 1-week is as safe and effective as the standard 3-week treatment.
May 10, 2025 at 8:35 PM
Proud to have contributed to this important study #RTQA
Congratulations to our very own Liz Miles, incredible colleague, mentor & friend on her #ESTRO25 Interdisciplinary Award. A true champion for #collaboration and #RTQA. So well deserved- we could not be prouder!
May 5, 2025 at 1:35 PM
Congratulations to our very own Liz Miles, incredible colleague, mentor & friend on her #ESTRO25 Interdisciplinary Award. A true champion for #collaboration and #RTQA. So well deserved- we could not be prouder!
Reposted by RTTQA
Congratulations Liz on your interdisciplinary award👏🏽🥳 @rttqa.bsky.social _UK does an incredible job ensuring that #radiotherapy is robust. Fantastic leadership! @nhsengland.bsky.social #ESTRO25
May 5, 2025 at 1:06 PM
Congratulations Liz on your interdisciplinary award👏🏽🥳 @rttqa.bsky.social _UK does an incredible job ensuring that #radiotherapy is robust. Fantastic leadership! @nhsengland.bsky.social #ESTRO25
Tightenining dose-volume constraints in oesophageal cancer to ensure best practice and further reduce toxicities. Geraint Lewis (Velindre Cancer Centre and @rttqa.bsky.social) presents modified #SCOPE2 trial constraints incorporated into the #PROTIEUS photon vs proton #clinicaltrial
May 4, 2025 at 4:34 PM
Tightenining dose-volume constraints in oesophageal cancer to ensure best practice and further reduce toxicities. Geraint Lewis (Velindre Cancer Centre and @rttqa.bsky.social) presents modified #SCOPE2 trial constraints incorporated into the #PROTIEUS photon vs proton #clinicaltrial
Dr Murray Brunt presents the excellent 10y results of the FAST-FORWARD #breast cancer trial. A pleasure to have contributed to this practice-changing #clinicaltrial
@nihr.bsky.social @icr-ctsu.bsky.social
@nihr.bsky.social @icr-ctsu.bsky.social
May 3, 2025 at 8:49 AM
Dr Murray Brunt presents the excellent 10y results of the FAST-FORWARD #breast cancer trial. A pleasure to have contributed to this practice-changing #clinicaltrial
@nihr.bsky.social @icr-ctsu.bsky.social
@nihr.bsky.social @icr-ctsu.bsky.social
Regional LN delineation variability in #BrCa RT within the Fast Forward trial. Despite this variability, all mandatory constraints were adhered to. #RTQA plays a central role in providing support & guidance to participating centres
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Regional Lymph Node Delineation variability and its Dosimetric Impact in Breast Cancer Radiotherapy
To quantify the interobserver variability of regional lymph node delineation for breast cancer radiotherapy (RT) and establish whether a relationship …
www.sciencedirect.com
April 21, 2025 at 4:46 PM
Regional LN delineation variability in #BrCa RT within the Fast Forward trial. Despite this variability, all mandatory constraints were adhered to. #RTQA plays a central role in providing support & guidance to participating centres
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Reposted by RTTQA
#NOTCH2025
✅ Quality Assurance is key in clinical trials, yet often overlooked! Dr. Sarah Gwynne SW Wales Cancer Centre (@rttqa.bsky.social) delivered an outstanding session on RT QA in the SCOPE trial
A fantastic deep dive into an essential aspect of oncology research 🎯
✅ Quality Assurance is key in clinical trials, yet often overlooked! Dr. Sarah Gwynne SW Wales Cancer Centre (@rttqa.bsky.social) delivered an outstanding session on RT QA in the SCOPE trial
A fantastic deep dive into an essential aspect of oncology research 🎯
March 25, 2025 at 3:58 PM
#NOTCH2025
✅ Quality Assurance is key in clinical trials, yet often overlooked! Dr. Sarah Gwynne SW Wales Cancer Centre (@rttqa.bsky.social) delivered an outstanding session on RT QA in the SCOPE trial
A fantastic deep dive into an essential aspect of oncology research 🎯
✅ Quality Assurance is key in clinical trials, yet often overlooked! Dr. Sarah Gwynne SW Wales Cancer Centre (@rttqa.bsky.social) delivered an outstanding session on RT QA in the SCOPE trial
A fantastic deep dive into an essential aspect of oncology research 🎯
Congrats Dr Tree! Proud to have supported the study.
TRAP trial results now out @ijrobp.bsky.social funded by @prostatecanceruk.bsky.social Men oligoprogressing on Abi/Enza for CRPC, nearly 40% progression-free 1 year after SBRT. No significant side effects due to radiotherapy.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Stereotactic body radiotherapy for oligoprogressive disease in androgen suppressed prostate cancer: Primary endpoint analysis of the TRAP trial
Optimal management of oligoprogressive prostate cancer whilst on androgen receptor pathway inhibitors (ARPi) is not known. The **** trial tests the ro…
www.sciencedirect.com
March 11, 2025 at 7:34 AM
Congrats Dr Tree! Proud to have supported the study.
Reposted by RTTQA
TRAP trial results now out @ijrobp.bsky.social funded by @prostatecanceruk.bsky.social Men oligoprogressing on Abi/Enza for CRPC, nearly 40% progression-free 1 year after SBRT. No significant side effects due to radiotherapy.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Stereotactic body radiotherapy for oligoprogressive disease in androgen suppressed prostate cancer: Primary endpoint analysis of the TRAP trial
Optimal management of oligoprogressive prostate cancer whilst on androgen receptor pathway inhibitors (ARPi) is not known. The **** trial tests the ro…
www.sciencedirect.com
March 10, 2025 at 8:43 AM
TRAP trial results now out @ijrobp.bsky.social funded by @prostatecanceruk.bsky.social Men oligoprogressing on Abi/Enza for CRPC, nearly 40% progression-free 1 year after SBRT. No significant side effects due to radiotherapy.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...